Suppr超能文献

林奇综合征患者结直肠癌和子宫内膜癌风险的计算。

Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.

作者信息

Stoffel Elena, Mukherjee Bhramar, Raymond Victoria M, Tayob Nabihah, Kastrinos Fay, Sparr Jennifer, Wang Fei, Bandipalliam Prathap, Syngal Sapna, Gruber Stephen B

机构信息

Brigham and Women's Hospital, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

出版信息

Gastroenterology. 2009 Nov;137(5):1621-7. doi: 10.1053/j.gastro.2009.07.039. Epub 2009 Jul 18.

Abstract

BACKGROUND & AIMS: Lynch syndrome is the most common hereditary colorectal cancer (CRC) syndrome. Some previous estimates of lifetime risk for CRC and endometrial cancer (EC) did not control for ascertainment and were susceptible to bias toward overestimated risk.

METHODS

We studied 147 families with mismatch repair gene mutations (55 MLH1, 81 MSH2, and 11 MSH6) identified at 2 US cancer genetics clinics. Age-specific cumulative risks (penetrance) and hazard ratio (HR) estimates of CRC and EC risks were calculated and compared with the general population using modified segregation analysis. The likelihood for each pedigree was conditioned on the proband and first-degree relatives affected with CRC to reduce ascertainment bias and overestimation of penetrance.

RESULTS

We analyzed 628 cases of CRC, diagnosed at the median ages of 42 and 47 years for men and women, respectively. The cumulative risk of CRC was 66.08% (95% confidence interval [CI], 59.47%-76.17%) for men and 42.71% (95% CI, 36.57%-52.83%) for women, with overall HRs of 148.4 and 51.1, respectively. CRC risk was highest for males with mutations in MLH1. There were 155 cases of EC, diagnosed at a median age of 47.5 years. The cumulative risk of EC was 39.39% (95% CI, 30.78%-46.94%) with an overall HR of 39.0 (95% CI, 30.4-50.2). For women, the cumulative risk of CRC or EC was 73.42% (95% CI, 63.76%-80.54%).

CONCLUSIONS

Lifetime risks of CRC and EC in mismatch repair gene mutation carriers are high even after adjusting for ascertainment. These estimates are valuable for patients and providers; specialized cancer surveillance is necessary.

摘要

背景与目的

林奇综合征是最常见的遗传性结直肠癌(CRC)综合征。先前对结直肠癌和子宫内膜癌(EC)终生风险的一些估计未对确诊情况进行控制,容易出现风险高估的偏差。

方法

我们研究了在美国两家癌症遗传学诊所确定的147个错配修复基因突变家族(55个MLH1、81个MSH2和11个MSH6)。使用改良的分离分析计算结直肠癌和子宫内膜癌风险的年龄特异性累积风险(外显率)和风险比(HR)估计值,并与一般人群进行比较。每个家系的可能性以上述综合征患者及其一级亲属患结直肠癌为条件,以减少确诊偏差和外显率的高估。

结果

我们分析了628例结直肠癌病例,男性和女性的诊断中位年龄分别为42岁和47岁。男性结直肠癌的累积风险为66.08%(95%置信区间[CI],59.47%-76.17%),女性为42.71%(95%CI,36.57%-52.83%),总体HR分别为148.4和51.1。MLH1基因突变的男性患结直肠癌的风险最高。有155例子宫内膜癌病例,诊断中位年龄为47.5岁。子宫内膜癌的累积风险为39.39%(95%CI,30.78%-46.94%),总体HR为39.0(95%CI,30.4-50.2)。对于女性,患结直肠癌或子宫内膜癌的累积风险为73.42%(95%CI,63.76%-80.54%)。

结论

即使在调整确诊情况后,错配修复基因突变携带者患结直肠癌和子宫内膜癌的终生风险仍然很高。这些估计值对患者和医疗服务提供者很有价值;需要进行专门的癌症监测。

相似文献

1
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.
Gastroenterology. 2009 Nov;137(5):1621-7. doi: 10.1053/j.gastro.2009.07.039. Epub 2009 Jul 18.
2
Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome.
Gastroenterology. 2015 Nov;149(6):1446-53. doi: 10.1053/j.gastro.2015.07.052. Epub 2015 Aug 3.
3
High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.
Gastroenterology. 2011 Jun;140(7):1919-26. doi: 10.1053/j.gastro.2011.02.071. Epub 2011 Mar 16.
5
Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.
Int J Cancer. 2010 Dec 1;127(11):2678-84. doi: 10.1002/ijc.25501.
6
Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome.
J Natl Cancer Inst. 2013 Feb 20;105(4):274-9. doi: 10.1093/jnci/djs525. Epub 2013 Feb 5.
7
Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families.
Acta Obstet Gynecol Scand. 2008;87(11):1129-35. doi: 10.1080/00016340802443806.
9
Cancer risks for MLH1 and MSH2 mutation carriers.
Hum Mutat. 2013 Mar;34(3):490-7. doi: 10.1002/humu.22262.

引用本文的文献

2
Reclassification of Two MLH1 Variants of Uncertain Significance Utilizing Clinical and Functional Data.
Mol Genet Genomic Med. 2024 Nov;12(11):e70026. doi: 10.1002/mgg3.70026.
3
4
[Gender-specific differences in the development of colorectal cancer in Lynch syndrome patients-A systematic review].
Chirurgie (Heidelb). 2024 Sep;95(9):696-708. doi: 10.1007/s00104-024-02159-x. Epub 2024 Aug 15.
6
Cascade genetic testing: an underutilized pathway to equitable cancer care?
Fam Cancer. 2024 Jun;23(2):141-145. doi: 10.1007/s10689-024-00367-2. Epub 2024 May 15.
7
Lynch Syndrome: From Multidisciplinary Management to Precision Prevention.
Cancers (Basel). 2024 Feb 20;16(5):849. doi: 10.3390/cancers16050849.
9
A Case of Lynch Syndrome-Associated Colorectal Adenocarcinoma in a 19-Year-Old Female Patient.
Cureus. 2023 Nov 13;15(11):e48740. doi: 10.7759/cureus.48740. eCollection 2023 Nov.
10
Molecular biomarkers for facilitating genome‑directed precision medicine in gynecological cancer (Review).
Oncol Lett. 2023 Aug 17;26(4):426. doi: 10.3892/ol.2023.14012. eCollection 2023 Oct.

本文引用的文献

3
Estimating cancer risk in HNPCC by the GRL method.
Eur J Hum Genet. 2007 Aug;15(8):831-6. doi: 10.1038/sj.ejhg.5201843. Epub 2007 May 2.
5
Prediction of germline mutations and cancer risk in the Lynch syndrome.
JAMA. 2006 Sep 27;296(12):1479-87. doi: 10.1001/jama.296.12.1479.
7
Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study.
Clin Gastroenterol Hepatol. 2006 Apr;4(4):489-98. doi: 10.1016/j.cgh.2006.01.002.
8
Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.
Gastroenterology. 2005 Aug;129(2):415-21. doi: 10.1016/j.gastro.2005.05.011.
10
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
N Engl J Med. 2005 May 5;352(18):1851-60. doi: 10.1056/NEJMoa043146.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验